双極性障害市場：現在・未来プレイヤー...市場調査レポートについてご紹介

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
2.3 Upcoming Related Reports
3 Market Outlook
3.1 Global Markets
3.1.1 Forecast
3.1.2 Drivers and Barriers – Global Issues
4 Current and Future Players
4.1 Overview
4.2 Trends in Corporate Strategy
4.3 Company Profiles
4.3.1 Otsuka
4.3.2 AstraZeneca
4.3.3 Eli Lilly
4.3.4 Allergan
4.3.5 Dainippon Sumitomo
4.3.6 Janssen
4.3.7 Lundbeck
4.3.8 Meiji Seika
5 Appendix
5.1 Bibliography
5.2 Abbreviations
5.3 Methodology
5.4 Forecasting Methodology
5.4.1 Diagnosed Bipolar Disorder Patients
5.4.2 Percent Drug-Treated Patients
5.4.3 Launch and Patent Expiry Dates
5.4.4 General Pricing Assumptions
5.4.5 Individual Drug Assumptions
5.4.6 Generic Erosion
5.5 Primary Research – KOLs Interviewed for this Report
5.6 Primary Research – Prescriber Survey
5.7 About the Authors
5.7.1 Analyst
5.7.2 Therapy Area Director
5.7.3 Epidemiologist
5.7.4 Global Director of Therapy Research and Analysis
5.8 About GlobalData
5.9 Disclaimer